about
Immunity to Pathogens Taught by Specialized Human Dendritic Cell SubsetsViral Vaccines and CTL ResponseTolerogenic dendritic cells: all present and correct?Natural splice variant of MHC class I cytoplasmic tail enhances dendritic cell-induced CD8+ T-cell responses and boosts anti-tumor immunity.Macrophage- and neutrophil-derived TNF-α instructs skin langerhans cells to prime antiviral immune responsesThree-day dendritic cells for vaccine development: antigen uptake, processing and presentation.Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma.Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice.MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells.Enhancement of dendritic cells as vaccines for cancerIn vivo delivery of nucleic acid-formulated microparticles as a potential tolerogenic vaccine for type 1 diabetes.Dendritic cell targeted vaccines: Recent progresses and challenges.The role of dendritic cells in CNS autoimmunity.Tolerogenic dendritic cells and myeloid-derived suppressor cells: potential for regulation and therapy of liver auto- and alloimmunity.Cellular vaccine approachesMultifunctional dendritic cell-targeting polymeric microparticles: engineering new vaccines for type 1 diabetes.Targeting human dendritic cell subsets for improved vaccines.Potential clinical applications for human pluripotent stem cell-derived blood components.Cutaneous dendritic cells in allergic inflammation.Dendritic cells and pluripotency: unlikely allies in the pursuit of immunotherapy.Development of a successful antitumor therapeutic model combining in vivo dendritic cell vaccination with tumor irradiation and intratumoral GM-CSF delivery.Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice.Comparative study of clinical grade human tolerogenic dendritic cells.Distinct features of dendritic cell-based immunotherapy as cancer vaccines.Increased tumor-specific CD8+ T cell induction by dendritic cells matured with a clinical grade TLR-agonist in combination with IFN-gamma.Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure.
P2860
Q26777195-C4AEEC9E-EB3D-4D64-9B49-36C69EBF17BFQ27491330-1FDD4B58-9F3F-4E4E-86C8-51616AA5FB38Q33811958-E96FD008-A5A4-47D2-9F5C-84A15E101E92Q34000832-13600280-5ECA-4D39-8039-3F0C76937AA8Q34053805-EF4E68CA-F637-4DAF-AC2B-F8AE3EE6E2DFQ34202646-17F8FA38-D89D-4186-B41E-3FF24C5CB849Q35166973-1101EB96-6C04-4E48-BB00-EFEE3582382CQ35606746-7CC62627-EF2E-4605-B445-848F9E1DBEB9Q36193536-4400B5DE-BDF5-47C3-91B6-EB32FFA7170CQ36209210-094D93CA-7102-4E9D-8847-287ABF1D915CQ37088220-1E9B4761-96F8-44F5-BB8B-8D30814E3B17Q37135259-B1926BC1-0529-46B2-B03B-7EB4D0C7E699Q37706120-6058A9DC-B22C-4DA0-A514-85ACAB272C0EQ37770271-4FA54A43-E3F7-4D3A-B64F-7C6309009C3EQ37778690-5B125B4C-C5FF-4A8C-A093-CB32F42AD397Q37820820-275C6C88-4259-43C7-8BEF-B862694AE6CFQ37833270-F500ABE4-F310-45A2-9673-8C24353EEB5AQ37857709-ED35A1AE-1B70-434D-9D6B-33D86A931A05Q38026993-AB1B5B7A-DB0C-4536-8EAD-90DA3A06D7C9Q38453644-C658B2BA-A014-4B24-80D4-55C350A7BAD0Q39631867-52135A86-4D72-4CC6-A9AB-48E261C519F0Q39665878-9B409DE2-5EB3-4FBC-98EA-0F866AF1B6D4Q42836981-EAB1BC70-3823-40D7-BDF2-ABE5F7F0AAE3Q48109150-3C0B9F7A-8AF7-49D5-A8E8-D2C6B18DB50EQ51059137-EE35A66F-4783-472C-A174-D2F74E1F31D9Q53091033-5DEE69D4-28A9-48FF-A309-FF9BB3A70EC0
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Harnessing dendritic cells to generate cancer vaccines.
@en
type
label
Harnessing dendritic cells to generate cancer vaccines.
@en
prefLabel
Harnessing dendritic cells to generate cancer vaccines.
@en
P2860
P1476
Harnessing dendritic cells to generate cancer vaccines.
@en
P2093
Joseph Fay
Karolina Palucka
P2860
P356
10.1111/J.1749-6632.2009.05000.X
P407
P577
2009-09-01T00:00:00Z